A series of GLM were carried out with PAD as the outcome variable and local ancestry status at position 2:216636519 (build 37) (0 = no NAT ancestry, 1 = heterozygous NAT, and 2 = homozygous NAT), test tag SNP, genotype chip, and sex as predictor variables. This evidence concerns the gene BRD2 and peripheral arterial disease.